EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
60 hedge funds and large institutions have $530M invested in ESSA Pharma in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less funds holding
Funds holding: 75 → 60 (-15)
71% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 21
Holders
60
Holding in Top 10
1
Calls
$171K
Puts
$9K
Top Buyers
| 1 | +$16.2M | |
| 2 | +$9.34M | |
| 3 | +$7.2M | |
| 4 |
ACM
Altium Capital Management
New York
|
+$4.9M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$4.63M |
Top Sellers
| 1 | -$6.89M | |
| 2 | -$5.8M | |
| 3 | -$4.43M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.86M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.57M |